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The maintenance of protein solubility is a funda-
mental aspect of cellular homeostasis because
protein aggregation is associated with a wide
variety of human diseases. Numerous proteins unre-
lated in sequence and structure, however, can mis-
fold and aggregate, and widespread aggregation
can occur in living systems under stress or aging. A
crucial question in this context is why only certain
proteins appear to aggregate readily in vivo, whereas
others do not. We identify here the proteins most
vulnerable to aggregation as those whose cellular
concentrations are high relative to their solubilities.
We find that these supersaturated proteins represent
a metastable subproteome involved in pathological
aggregation during stress and aging and are over-
represented in biochemical processes associated
with neurodegenerative disorders. Consequently,
such cellular processes become dysfunctional
when the ability to keep intrinsically supersaturated
proteins soluble is compromised. Thus, the simulta-
neous analysis of abundance and solubility can ratio-
nalize the diverse cellular pathologies linked to
neurodegenerative diseases and aging.INTRODUCTION
Neurodegenerative disorders are increasingly prevalent in our
society and represent a very significant challenge to healthcare
systems (Balch et al., 2008; Dobson, 2003). A number of expla-
nations of the fundamental origins of these diseases have been
proposed, including mitochondrial dysfunction, disruptions of
the endoplasmic reticulum and membrane trafficking, effects
on protein folding and clearance, and the activation of inflamma-
tory responses (Balch et al., 2008; Dobson, 2003; Querfurth and
LaFerla, 2010; Selkoe, 2011). One common feature associated
with these conditions, however, is the aggregation of certainCepeptides and proteins, which generates a cascade of patholog-
ical events, including the secondary aggregation of various other
proteins and the consequent failure of protein homeostasis to
preserve normal biological function (Balch et al., 2008; Dobson,
2003; Gidalevitz et al., 2006; Selkoe, 2011).
Given the evidence that protein aggregation is a widespread
phenomenon (Chapman et al., 2006; David et al., 2010; Gidale-
vitz et al., 2006; Koga et al., 2011; Koplin et al., 2010; Liao
et al., 2004; Narayanaswamy et al., 2009; Olzscha et al., 2011;
Reis-Rodrigues et al., 2012; Wang et al., 2005; Xia et al., 2008),
two key questions are why some proteins, but not others, aggre-
gate in vivo and generate pathological states, and whether or not
the identities of these proteins differ substantially between dis-
eases. If particular proteins aggregate in response to specific
stresses, different sets of aggregated proteins will appear under
each condition. Alternatively, the various sets of aggregating
proteins may correspond to a fraction of the proteome with
distinctive characteristics that increase the risk of aggregation
under many kinds of stress. The latter possibility is consistent
with observations that aggregation-prone proteins share general
physicochemical features (Chiti et al., 2003; Fernandez-Esca-
milla et al., 2004; Olzscha et al., 2011; Tartaglia et al., 2008).
Our aim in this work has been to answer a fundamental ques-
tion about widespread protein aggregation: why certain proteins
aggregate in stress, aging, or disease, whereas others do not. To
address this problem, we have sought to establish a proteome-
wide method of identifying the proteins that are vulnerable to
aggregation in vivo. Using this method, we have identified a
number of proteins that are expressed at levels that are high
relative to their solubilities. These proteins are supersaturated
because their concentrations exceed their solubility levels. Early
evidence that supersaturation predisposes proteins to aggre-
gate was provided by the finding that the rate and extent of ag-
gregation of hemoglobin S, which is associated with sickle cell
anemia, are strongly concentration dependent (Hofrichter
et al., 1976). More recently, this idea has been used to compare
the aggregation and crystallization behavior of proteins (Yoshi-
mura et al., 2012). Here, we have extended the concept of
supersaturation to the proteome level by considering both the
unfolded and folded states that can be populated by individual
proteins, as well as their association into complexes. Thus, forll Reports 5, 781–790, November 14, 2013 ª2013 The Authors 781
Figure 1. Protein Aggregation In Vivo Can Occur through Different
Routes
Proteins may misfold and aggregate as they emerge from the ribosome or
when they unfold at least transiently from the native state. The proteins most at
risk for aggregation are those whose concentrations are high with respect to
their solubilities. We quantify this risk by defining the supersaturation su and sf
scores. The supersaturation score su, which measures the tendency of pro-
teins to aggregate from the unfolded state, is based on the Zyggregator score
(Tartaglia et al., 2008) (Zagg ) and mRNA expression levels. The supersaturation
score sf , which measures the tendency of proteins to aggregate from the
folded state, is based on the structurally corrected Zyggregator score (Tar-
taglia et al., 2008) (ZSCagg ) and protein concentration. See also Tables S1 and S3.example, an intrinsically aggregation-prone protein is not neces-
sarily dangerous unless it is expressed at a relatively high con-
centration. Similarly, a highly concentrated protein may not be
at risk of losing its solubility unless its intrinsic propensity to
aggregate is relatively high.
By predicting supersaturation from estimated protein concen-
trations and aggregation propensities at a proteome scale, we
are able to rationalize a variety of phenomena associated with
aggregation and misfolding diseases. We find through our anal-
ysis of the human and C. elegans proteomes that those proteins
known to interact with aggregates or to aggregate upon aging
are highly supersaturated and that the cellular processes known
to be associated with neurodegenerative diseases are at risk of
disruption because they involve an exceptionally large number of
supersaturated proteins. These results show how the initial
appearance of protein aggregates in the presence of other
vulnerable proteins can precipitate a series of uncontrolled
aggregation events with severe pathological consequences
and that proteins in a supersaturated state comprise the subpro-
teome most at risk of misfolding and aggregation under condi-
tions of stress. These proteins and the biochemical pathways
to which they belong may be the first to suffer from an impair-
ment of protein homeostasis and, therefore, represent the
underlying basis for the cellular damage caused by diseases
of misfolding, including neurodegenerative conditions such as
Alzheimer’s, Huntington’s, and Parkinson’s diseases.
RESULTS
Prediction of Protein Supersaturation from
Concentration and Aggregation Propensity
In order to identify those proteins most at risk of misfolding and
aggregating in vivo, we calculated their level of supersaturation782 Cell Reports 5, 781–790, November 14, 2013 ª2013 The Authorsusing a score that we define in terms of the concentrations of
proteins relative to their aggregation propensities (see Experi-
mental Procedures; Supplemental Experimental Procedures).
The cellular concentrations of proteins with high supersaturation
scores are more likely to exceed their critical values under vary-
ing conditions, leading these proteins to become insoluble. We
here used the aggregation propensities of proteins as estimates
of their solubility because experimental measurements of critical
concentrations of proteins in vivo are extremely difficult to carry
out at the proteome level. To evaluate the risk of proteins to
aggregate from their unfolded or native states, we define the
parameters su and sf as the supersaturation scores, respectively
(Figure 1). The risk of aggregation is different in these two states
because in the folded state the most aggregation-prone regions
tend to be buried in the core of the structure, and thus they are
prevented from forming intermolecular interactions (Tartaglia
et al., 2008). The critical concentrations of proteins in their
unfolded states thus are generally expected to be lower than in
their folded states, hence the necessity of introducing the su
and sf scores separately. Because the largest pool of unfolded
proteins corresponds to newly synthesized proteins, whose con-
centrations can be estimated from the corresponding mRNA
concentrations, we used the logarithmic average of scores
derived from microarray analysis of over 70 types of human tis-
sue or of the nematodeC. elegans at a range of ages to represent
levels of newly synthesized proteins (Golden et al., 2008; Su
et al., 2004). For folded proteins, in order to define the sf score,
we used the logarithm of the normalized spectral abundance fac-
tors (NSAFs) derived from mass spectrometry (Schrimpf et al.,
2012).
We estimated the propensity of proteins to aggregate from the
unfolded state using the Zagg score calculated with the Zyggre-
gator method (Tartaglia et al., 2008), which is based on the anal-
ysis of the physicochemical properties of amino acid sequences
(Chiti et al., 2003). The Zyggregator method employs algorithms
that have been parameterized to reproduce the aggregation
behavior of a set of known amyloidogenic proteins and has
been validated in a series of studies in which it has been shown
to lead to accurate predictions of aggregation rates both in vitro
and in vivo (Belli et al., 2011; Luheshi et al., 2007; Roodveldt
et al., 2012; Tartaglia et al., 2008). For proteins that aggregate
from the native state, we used an aggregation propensity score
that accounts for the protective effects of the folded structure,
which is defined by assigning corrections to the aggregation pro-
pensities of individual residues on the basis of the extent of the
structural fluctuations that they experience in the folded state
and that lead to their temporary exposure to the solvent (Tarta-
glia et al., 2008). This structurally corrected aggregation propen-
sity score (ZSCagg) has been shown to correlate well with protein
solubility determined from an in-vitro-reconstituted bacterial
ribosome system (Agostini et al., 2012). We then summed the
logarithms of the concentration and aggregation propensity
values (see Experimental Procedures; Supplemental Experi-
mental Procedures) to construct a human database of su scores
for 16,263 proteins and sf scores for 6,155 proteins, and a
C. elegans database of su scores for 16,623 proteins and sf
scores for 10,149 proteins (Table S2). The sizes of our databases
were limited primarily by the availability of expression and
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Figure 2. Widespread Protein Aggregation
Is Associated with High Supersaturation
Scores
(A–G) Summary of the results for the different
classes of aggregating proteins analyzed in this
work. Results are given in terms of the increases in
the supersaturation scores over the average value
for the whole proteome or for an experimental
lysate (‘‘fold change’’ [FC]). We compared the su-
persaturation scores sf for (B) the whole proteome
and the human ‘‘amyloid proteins’’ in UniProt
(UniProt Consortium, 2012), (C) the whole prote-
ome and proteins that coprecipitate in amyloid
plaques (Liao et al., 2004), (D) the whole proteome
and proteins that coprecipitate in neurofibrillary
tangles (NFTs) (Wang et al., 2005), (E) the whole
lysate and proteins that coprecipitate in Lewy
bodies (Xia et al., 2008), (F) the whole lysate and
proteins that coprecipitate in artificial b sheet
protein aggregates (Olzscha et al., 2011), and (G)
the whole proteome and proteins found to aggre-
gate in C. elegans during aging (David et al., 2010;
Reis-Rodrigues et al., 2012). Boxplots extend from
the lower to the upper quartiles, with the internal
lines referring to the median values. Whiskers
range from the lowest to highest value data points
within 150% of the interquartile ranges. The
statistical significance was assessed by the Wil-
coxon/Mann-Whitney U test with Bonferroni-cor-
rected p values (*p < 0.05, **p < 0.01, and ****p <
0.0001). See also Figures S1–S3, S5, and S6.abundance data that could be unambiguously mapped to spe-
cific protein identifiers.
Supersaturation Scores RationalizeWidespread Protein
Aggregation under Stress
Because a wide range of proteins is known to form fibrillar
assemblies within the cell (Chapman et al., 2006; Chiti and Dob-
son, 2006; David et al., 2010; Fowler et al., 2007; Gidalevitz et al.,
2006; Haass and Selkoe, 2007; Hartl et al., 2011; Koplin et al.,
2010; Liao et al., 2004; Olzscha et al., 2011; Reis-Rodrigues
et al., 2012; Wang et al., 2005; Xia et al., 2008), we investigated
the relationship between the phenomena of supersaturation
and aggregation. For instance, the function of actin, a highly
abundant protein also identified as being highly supersaturated
in our calculations (Table S2), relies on its ability to assemble
reversibly into filaments, and it has been suggested that givenCell Reports 5, 781–790, Nthe typical cytosolic concentration of
actin, it would always remain in a poly-
merized form were it not for the presence
of specific regulatory mechanisms
(Pollard et al., 2000).
More generally, we find that the ‘‘amy-
loid proteins,’’ as annotated in theUniProt
database (UniProt Consortium, 2012),
have elevated supersaturation scores
(Figures 2A, 2B, S1A, S1B, S1H, and
S1I). For these proteins, the sf score is
more than 500-fold greater than the me-dian value over the proteome (5403, p = 1.9 3 105), indicating
that these proteins are on average at greater risk for aggregation
upon accumulation in the cell (Figures 2A and 2B) thanwhen they
are in the process of being synthesized (Figures S1A and S1B).
This conclusion is consistent with the appearance of such pro-
teins as the predominant constituents of either intracellular inclu-
sions or extracellular deposits in a variety of diseases (Balch
et al., 2008; Dobson, 2003).
Given that high supersaturation scores correspond to an
increased risk of proteins becoming insoluble, we investigated
whether such scores can rationalize additional aspects of protein
aggregation, including coaggregation with large, insoluble de-
posits associated with disease (Liao et al., 2004; Wang et al.,
2005; Xia et al., 2008) and artificial b sheet protein (Olzscha
et al., 2011) aggregates. Our results indicate that the sf score
can identify proteins found to incorporate into amyloid plaquesovember 14, 2013 ª2013 The Authors 783
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Figure 3. Biochemical Processes Associated with Neurodegenera-
tive Diseases Are Highly Enriched in Supersaturated Proteins
(A) List of the KEGG pathways (Kanehisa et al., 2010) identified here as
significantly enriched (Bonferroni-corrected p values) in proteins at or above
the 95th percentile of supersaturation (su): R, ribosome; OP, oxidative phos-
phorylation; PD, Parkinson’s disease; HD, Huntington’s disease; AD, Alz-
heimer’s disease; CMC, cardiac muscle contraction; PecI, pathogenic E. coli
infection; Pr, proteasome. Physiological and pathological pathways are shown
in blue and red, respectively.
(B and C) Test of the robustness of the significance of the enrichment of the
KEGG pathways according to their supersaturation scores. Gaussian noise
was introduced 100 independent times into the proteome scores at 50
different levels and plotted (13, no noise) for (B) physiological pathways, which
are robust up to 283 (R), 8.83 (OP), 2.33 (CMC), and 1.23 (Pr), and (C)
pathological pathways, which are robust up to 8.23 (PD), 6.23 (HD), 5.53
(AD), and 2.13 (PEcI). Error bars indicate interquartile ranges; green points
indicate error levels below the p = 0.05 significance (red dashed line) by the
Wilcoxon/Mann-Whitney U test.
See also Figures S4 and S6.(Liao et al., 2004) (2003, p = 1.7 3 107, Figures 2A and 2C),
neurofibrillary tangles (Wang et al., 2005) (1403, p = 1.2 3
1018, Figures 2A and 2D), and Lewy bodies (Xia et al., 2008)
(2.53, p = 2.9 3 103, Figures 2A and 2E) isolated from autopsy
samples of patients with neurodegenerative disease. We find
that proteins that coaggregate with artificial b sheet proteins in
human cell cultures (Olzscha et al., 2011) are characterized by
increased values of the sf score (3.53, p = 1.7 3 10
6, Figures
2A and 2F), as well. Such proteins also have elevated su
scores (1.43, p = 1.4 3 102, Figures S1A and S2F), consistent
with observations from pulse-chase experiments that both784 Cell Reports 5, 781–790, November 14, 2013 ª2013 The Authorsnewly synthesized and preexisting proteins interact with aggre-
gates (Olzscha et al., 2011). The sf (Figure 2) and su (Figure S1)
scores are broadly consistent for all of these sets, with pro-
teins that coaggregate with large inclusions tending to be
relatively highly supersaturated in both the folded and unfolded
states.
We then turned our attention to the analysis of proteins that are
likely to become susceptible to aggregation when the control of
protein homeostasis declines, as in aging (David et al., 2010;
Reis-Rodrigues et al., 2012). We observe that the su scores
(0.613, p = 2.0 3 1085, Figures S1A and S1G) of proteins that
aggregate upon aging in C. elegans (David et al., 2010; Reis-
Rodrigues et al., 2012) are lower than those of the proteome as
a whole; by contrast, the sf scores aremuch higher for these pro-
teins (353, p =1.9310158, Figures2Aand2G). The lowvaluesof
thesu scorescanbeattributed to the fact that global geneexpres-
sion in C. elegans declines with age (Golden et al., 2008), thus
reducing the levels of newly synthesized proteins thatmay aggre-
gate from their unfolded states. Instead, proteins that aggregate
during aging have low expression levels but relatively high con-
centrations and tend to be metastable by virtue of their high sf
scores.
Because both the estimates of concentration and the predic-
tions of aggregation propensity are subject to considerable
potential errors, to test the robustness of our results against
these errors, we introduced Gaussian noise into the calculations
of the sf and su scores, finding that the results are indeed stable
against high levels of noise (in many cases, more than 50-fold
error, Figures S2 and S3).
Biochemical Pathways Associated with
Neurodegenerative Diseases Are Enriched in
Supersaturated Proteins
Because supersaturation scores are able to explain diverse phe-
nomena related directly to aggregation, we wondered whether
they might help identify cellular processes particularly sensitive
to stress. Therefore, we asked whether particular biochemical
pathways are at high risk for disruption by virtue of the supersat-
uration levels of their constituent proteins. For our analysis, we
considered the pathways that are listed in the Kyoto Encyclo-
pedia of Genes and Genomes (KEGG), which are based on
manually curated sets of proteins involved in cellular processes
or proposed to be involved in disease on the basis of reports in
the literature. We used the DAVID software (Huang et al., 2009)
to determine if any of the KEGG pathways (Kanehisa et al.,
2010) have a large number of human proteins with high su or sf
scores. We carried out an unbiased search of the roughly 200
KEGG pathways and found only 8 pathways significantly en-
riched in the proteins with su scores at or above the 95
th percen-
tile. Strikingly, all these pathways involve proteins that either
form well-defined functional complexes or are related to dis-
eases that involve pathological protein complexes. The three
disease pathways that are most dramatically enriched in super-
saturated proteins are those of Alzheimer’s (p = 6.0 3 1017),
Parkinson’s (p = 1.1 3 1028), and Huntington’s (p =
4.0 3 1022) diseases (Figure 3A). A fourth pathway, involved
in pathogenic E. coli infection, which is closely associated with
the cytoskeleton, is also enriched but to a much less significant
Figure 4. Supersaturated Proteins Are Overrepresented in the KEGG Alzheimer’s Disease Pathway
The KEGG pathway for Alzheimer’s disease (Kanehisa et al., 2010) is curated from the literature and includes many proteins not directly associated with the
disruption of the homeostasis of the Ab peptide. Those proteins that are part of the overlap (see Figure 5A) of the Alzheimer’s, Parkinson’s, and Huntington’s
disease pathways are shown in bold. Approximately 65%of proteins in the Alzheimer’s pathway have high su scores. Colors are assigned based on the division of
the su database into deciles from low (green) to high (red).level (p = 4.63 103). KEGG pathways are broadly constructed,
with those related to neurodegenerative diseases including not
only proteins known to aggregate but also the proteins that pro-
cess these aggregates and the cellular systems that become
impaired as a result of aggregation (Kanehisa et al., 2010).
Despite this disparate collection of proteins, a staggering two-Cethirds of proteins in the KEGG Alzheimer’s disease pathway
have supersaturation scores above the median value for the
human proteome (Figure 4).
In addition to these disease pathways, we also find that the
KEGG pathways associated with the assembly of the ribosome
(p = 4.0 3 1053) and the proteasome (p = 3.2 3 102), andll Reports 5, 781–790, November 14, 2013 ª2013 The Authors 785
A B
Figure 5. Supersaturated Proteins Are Common to Different
Neurodegenerative Pathways
(A) Comparison of the su scores for the proteome and the set of 76 proteins
common among the Alzheimer’s, Parkinson’s, and Huntington’s KEGG path-
ways (Kanehisa et al., 2010); this set of proteins is denoted as ‘‘overlap.’’ ****p <
0.0001.
(B) Comparison of the su scores for the proteins in the Alzheimer’s, Parkin-
son’s, and Huntington’s pathways. Colors are assigned based on the division
of the su scores into deciles from low to high (color code as in Figure 4).
See also Figures S2–S6.with the processes of oxidative phosphorylation (p = 8.83 1033)
and cardiac muscle contraction (p = 3.93 105), are enriched in
supersaturated proteins (Figure 3A). These results, particularly
those associated with the ribosome and oxidative phosphoryla-
tion, are highly robust against errors in the calculation of su
scores (Figure 3B). All of these pathways involve the assembly
of major cellular macromolecular complexes, the components
of which must contain interactive surfaces that tend to be aggre-
gation prone (Pechmann et al., 2009). In agreement with this
finding, proteins involved in such assemblies, especially the
ribosome, have been observed consistently in widespread
aggregation studies (David et al., 2010; Koplin et al., 2010;
Reis-Rodrigues et al., 2012). Significantly, none of the pathways
identified by using supersaturation scores is identifiable from
aggregation propensities alone.
These results suggest that widespread aggregation under
conditions of stress is defined not only by the specific nature
of the stress itself but also by the level of supersaturation of
the proteins that aggregate. If this is the case, some proteins
should have characteristics that render them susceptible to
aggregation under a variety of conditions. To investigate this
possibility, we determined the overlap among the Alzheimer’s,
Parkinson’s, and Huntington’s disease KEGG pathways. The
76 proteins common to the pathways represented by these dis-
eases have on average a much larger su score (193, p = 4.2 3
1031) than that of the proteome as a whole (Figure 5A), or
indeed, that of the remaining proteins in the three individual path-
ways (Figure 5B).
Of the eight pathways enriched in proteins with high su scores,
five, including those for Alzheimer’s, Parkinson’s, and Hunting-
ton’s diseases, are also enriched in proteins with high sf scores,
although in the latter case, the data are less statistically signifi-
cant (Figure S4). The fact that the su scores so strongly single
out pathways involved in neurodegeneration suggests that the786 Cell Reports 5, 781–790, November 14, 2013 ª2013 The Authorsproteins that misfold and aggregate during the course of these
diseases aggregate primarily from unstructured or partially
unstructured states. In particular, because many proteins in
the KEGG neurodegenerative disease pathways are membrane
proteins, they are unlikely to aggregate from their folded state
in the membrane environment. They are, however, likely to be
at risk during folding or upon removal from the membrane
for degradation (MacGurn et al., 2012; Notterpek et al., 1999;
Skach, 2009), especially if protein homeostasis dysfunction
impairs membrane trafficking, as has been reported by Cooper
et al. (2006). Consistent with the view that membrane proteins
may have a somewhat elevated risk of aggregation in the
unfolded state is that the median su score is modestly elevated
for proteins with ‘‘membrane’’ Gene Ontology (Ashburner et al.,
2000) tag (1.23, p = 1.7 3 1020), whereas the sf score is low
for such proteins (0.473, 5.9 3 1052). This risk, therefore, is
small compared to that of most sets of aggregating proteins in
Figure 2. In order to test whether or not the observation that
the Alzheimer’s, Parkinson’s, and Huntington’s disease path-
ways have elevated numbers of supersaturated proteins is sim-
ply a consequence of their richness in membrane proteins, we
determined whether or not the sets of proteins at or above the
95th percentile of su or sf scores are significantly enriched in
membrane proteins compared to the proteome at large. Our re-
sults indicate that the most supersaturated proteins are not en-
riched in this way (su : p = 0.16, sf : p = 1.0). However, we do
find that the proteins most supersaturated in the unfolded state
are enriched in those associated with the Gene Ontology tag
‘‘organelle membrane’’ (su : p = 6.9 3 10
19, sf : p = 1.0). This
result is consistent with recent evidence that membrane proteins
in the mitochondrial respiratory chain can misfold when the Par-
kinson’s-associated gene PINK1 is mutated (Pimenta de Castro
et al., 2012). In fact, predominant among the overlapping pro-
teins in the Alzheimer’s, Parkinson’s, and Huntington’s disease
pathways are the proteins that are members of the respiratory
chain.
Because coaggregating proteins are more highly supersatu-
rated in the folded state than in the unfolded state, the ability
of the su score, in addition to the sf score, to identify disease
pathways suggests at least three possibilities. First, it may be
that many proteins involved with disease aggregate indepen-
dently instead of associating with inclusions, as suggested by
the tendency of proteins toward homomeric aggregation (Matsu-
moto et al., 2006; Rajan et al., 2001; Wright et al., 2005). Second,
proteins involvedwith diseasemay be degraded if they fail to fold
into their native conformation (Goldberg, 2003). Third, because
mass spectrometry experiments designed to identify aggre-
gating or coaggregating proteins tend to ignore membrane pro-
teins because of the difficulty of distinguishing them from truly
insoluble ones, these experiments may be missing an important
component of the disease process. Despite the need for such
details to be resolved in the future, our results suggest that su-
persaturation in the folded state is reporting on significant func-
tional properties of proteins in the cell, as well as on potentially
pathological processes. We find, for example, that in addition
to proteins that aggregate (Figure 2), those proteins that form
functional complexes tend to have high sf scores (complexes
[Licata et al., 2012]: 6.23, p = 2.3 3 1058; nuclear complexes
A B
Figure 6. Proteins that Form Complexes Tend to Be More Super-
saturated than the Proteome as a Whole
(A and B) We compared the sf scores for (A) the proteome and proteins
involved in complexes and (B) the nuclear proteome (Nucl. prot.) and proteins
involved in nuclear complexes (Nucl. cpx.). Boxplots extend from the lower to
the upper quartiles, with the internal lines referring to the median values.
Whiskers range from the lowest to highest value data points within 150%of the
interquartile ranges. The statistical significance was assessed by the
Wilcoxon/Mann-Whitney U test with Bonferroni-corrected p values (**p < 0.01
and ****p < 0.0001). See also Figures S2 and S5.[Luc and Tempst, 2004]: 1.73, p = 1.2 3 103, Figure 6). These
results are consistent with evidence that the features that
mediate normal protein interactions are similar to those that pro-
mote aggregation (Pechmann et al., 2009).
To test our results for the su scores, we used another predictor
of aggregation from the unfolded state, the TANGO algorithm
(Fernandez-Escamilla et al., 2004). A supersaturation score
based on this algorithm (suT ) (Table S2) produces similar results
to those obtained with the su score (Figure S1). Furthermore, to
test the possibility that the su and sf scores may give too much
weight to the expression levels relative to the aggregation pro-
pensities, we increased the exponential weight of aggregation
propensities in the su and sf score. At the highest reweighting
that we tested (Figures S5 and S6), supersaturation scores
are more strongly correlated with aggregation propensity (hu-
man Zagg, su : 0.88; human Z
SC
agg, sf : 0.88; worm Zagg, su : 0.99;
and worm ZSCagg, sf : 0.96) than concentration score (human
mRNA expression, su : 0.35; human protein abundance,sf :
0.53; worm mRNA expression, su : 0.10; and worm protein
abundance,sf : 0.015). We find that most of our results are
robust over a wide range of weights for the aggregation propen-
sity (Figures S5 and S6).
Nevertheless, we observed that concentration is a strong pre-
dictor of the variety of aggregation-related phenomena that we
have analyzed in this work because an important component of
the predictive power of sf is attributable to this property. Indeed,
the widespread aggregation data sets that we considered tend
to exhibit protein abundance levels more elevated than corre-
sponding mRNA levels, and whereas they also tend to be
more elevated in ZSCagg than Zagg, the difference is much smaller
(Figure S1). In addition, the ratio of relative sf -to-su values is
positively correlated with the ratio of relative protein abun-Cedance-to-mRNA levels but negatively correlated with the ratio
of relative ZSCagg -to-Zagg levels (Figure S1). The relevance of the
concentration levels in rationalizing widespread aggregation
measurements is a further indication that the concepts of solu-
bility and supersaturation are key in understanding these data.
Moreover, because both the procedures adopted for pathway
construction in the KEGG database (Kanehisa et al., 2010) and
the identification of aggregating proteins using mass spectrom-
etry (Olzscha et al., 2011) typically consider only the more abun-
dant proteins, the use of the supersaturation score helps to
identify additional proteins that aggregate in disease, particularly
those with low concentrations and high aggregation propen-
sities. For example, pathways related to cell surface receptors,
including olfactory transduction (p = 4.0 3 1090) and neuroac-
tive ligand-receptor interaction (p = 4.9 3 105), are enriched
among those supersaturated proteins that are present at low
concentrations.
DISCUSSION
Previous studies that have investigated the causes of proteome-
wide aggregation have considered the intrinsic aggregation pro-
pensities of proteins (Goldschmidt et al., 2010; Monsellier et al.,
2008; Tartaglia et al., 2005; Tartaglia and Vendruscolo, 2010). It
has thus been suggested that a diverse collection of proteins can
form aggregates, although the presence of molecular chaper-
ones and clearance processes largely prevents proteome-wide
aggregation under stress-free conditions (Dobson, 2003; Gold-
schmidt et al., 2010; Lindquist and Kelly, 2011; Monsellier
et al., 2008; Olzscha et al., 2011). It has also been shown that de-
stabilizingmutationsmay drive soluble proteins toward aggrega-
tion and that a genetic background predisposed to such defects
can exacerbate this problem (Gidalevitz et al., 2006; Luheshi
et al., 2007). More generally, because protein aggregation in
the cellular environment has potentially devastating effects, the
expression of aggregation-prone proteins is generally main-
tained at low levels (Tartaglia et al., 2007) and tightly regulated
(Gsponer and Babu, 2012). It has been observed, however,
that proteins are only just soluble at the levels at which they
are expressed in the cell (Tartaglia et al., 2007) and because
these trends are conserved in the yeast, mouse, and human pro-
teomes, it has been suggested that monomeric and aggregated
forms of proteins are in an effective homeostatic state (Gsponer
and Babu, 2012). Similarly, it was recently shown that highly
abundant proteins have fewer aggregation-prone surfaces, an
observation consistent with their low aggregation propensities
(Levy et al., 2012; Tartaglia et al., 2007). Given these evolutionary
constraints, it may be surprising that in vivo aggregation is such a
common phenomenon under stress (Chapman et al., 2006;
Gidalevitz et al., 2006; Koplin et al., 2010; Liao et al., 2004; Nar-
ayanaswamy et al., 2009; Olzscha et al., 2011; Wang et al., 2005;
Xia et al., 2008) or aging (David et al., 2010; Koga et al., 2011;
Reis-Rodrigues et al., 2012). Our results on protein supersatura-
tion provide an explanation for these observations because they
indicate that not only the intrinsic propensities of proteins to
aggregate but also their cellular concentrations are key factors
that distinguish aggregation-prone proteins from those whose
homeostasis is more robust (Tables 1 and S2). Although it hasll Reports 5, 781–790, November 14, 2013 ª2013 The Authors 787
Table 1. Summary of Widespread Aggregation Data sets Analyzed in this Work
Data Set References Species
Original
Number
Number of
UniProt IDs # su # sf # suT
Amyloids UniProt Consortium, 2012 human 27 27 20 13 20
Plaques (coaggregators) Liao et al., 2004 human 26 26 26 18 26
NFTs (coaggregators) Wang et al., 2005 human 72 88 75 52 75
Lewy bodies (coaggregators) Xia et al., 2008 human 36 34 33 22 33
Lewy bodies (detected) Xia et al., 2008 human 707 557 538 380 538
Artificial b (coaggregators) Olzscha et al., 2011 human 133 151 141 97 140
Artificial b (lysate) Olzscha et al., 2011 human 3,055 3,032 2,778 1,858 2,758
Aging aggregators David et al., 2010 worm 720 719 517 577 512
Aging aggregators Reis-Rodrigues et al., 2012 worm 203 203 160 178 159
Complexes Licata et al., 2012 human 1,729 1,637 – 941 –
Nuclear complexes Luc and Tempst, 2004 human 604 630 – 319 –
Nuclear proteome Ashburner et al., 2000; Huang et al., 2009 human – 1,942 – 1,942 –
Membrane proteins Ashburner et al., 2000; Huang et al., 2009 human – – 6,167 2,285 6,140
‘‘Data Set’’ is a description of the data used. ‘‘References’’ indicate the references for the data. ‘‘Species’’ indicates the species to which the data refer.
‘‘Original Number’’ is the number of data points listed in the original published set. ‘‘Number of UniProt IDs’’ is the number of data points listed after
conversion to UniProt ID. For human proteins, only the reviewed UniProt IDs are counted. No. su, no. sf , and no. suT are the number of those proteins in
the Number of UniProt IDs column, the number for which the given score is available.
See also Table S1.been observed that widespread aggregation occurs upon over-
expression, which raises the supersaturation levels (Gsponer
and Babu, 2012; Narayanaswamy et al., 2009; Sopko et al.,
2006), our results indicate that a substantial fraction of the prote-
ome is intrinsically supersaturated and therefore requires the
constant aid of quality control mechanisms such as molecular
chaperones to remain soluble.
The example of serum albumin illustrates some of the strate-
gies adopted by supersaturated proteins to avoid aggregation,
as well as their limitations. Albumin, which is exceptionally abun-
dant, is classified in our analysis as supersaturated (Table S2).
This protein, which is ubiquitous in the serum, is usually consid-
ered to be very soluble, and yet it has been observed to aggre-
gate in vitro (Costantino et al., 1995; Maruyama et al., 2001)
and to form toxic aggregates in the synovial fluid of patients
with rheumatoid arthritis (Oates et al., 2006). These findings
reflect two important aspects that regulate the behavior of
supersaturated proteins: the volume that they occupy, and the
interactions that they form. Although albumin is highly abundant
in the serum, its concentration is still relatively low owing to the
large volume of the serum itself. By contrast, when confined in
the synovial fluid, which has a smaller volume, the concentration
of albuminmay become substantially higher. In addition, albumin
forms numerous complexes with proteins and other molecules,
which may protect it from aggregation, as has been observed
for the ribosomal proteins (David et al., 2010; Koplin et al.,
2010; Reis-Rodrigues et al., 2012). Future studies should
account for the volume occupied by proteins and the complexes
they form in order to increase the accuracy of supersaturation
predictions.
Although abundant proteins have evolved to be more soluble
than those that are of low abundance (Tartaglia et al., 2007),
some proteins are expressed at such high concentrations that788 Cell Reports 5, 781–790, November 14, 2013 ª2013 The Authorsit may be impossible for them to achieve the necessary solubility
with the constraints of functionality and the need for a stable
hydrophobic core. We have indeed found that abundance itself
is also a good predictor of widespread aggregation in vivo.
This result indicates that highly abundant proteins are intrinsi-
cally more at risk of aggregation than low-abundant proteins (Ta-
ble S3), which in turn suggests that highly abundant proteins
must be maintained at high solubility levels by the protein ho-
meostasis system. These proteins are therefore more suscepti-
ble to aggregation in processes that impair protein homeostasis,
such as stress, aging, or disease. The strong predictive power of
abundance underscores the importance of solubility in this
phenomenon.
Supersaturated proteins are kinetically, but not thermodynam-
ically, stable in their soluble states (Baldwin et al., 2011; Gazit,
2002; Yoshimura et al., 2012) and are, thus, likely to be highly
dependent on the systems that control protein homeostasis in
order to remain soluble. The instability of supersaturated pro-
teins is thus expected to arise from the failure of cellular systems
that contribute to keeping them soluble. The disruption of this
machinery under stress and in disease conditions leads to the
aggregation of such proteins by shifting the protein homeostasis
boundary for their solubility (Hutt et al., 2009; Taylor and Dillin,
2011). The present study suggests that a widespread failure to
maintain proteins in their soluble functional states underlies the
diverse and complex pathophysiology of neurodegenerative
diseases. The sensitivity of neurons to protein aggregation,
therefore, may arise from their high dependence on classes of
proteins, such as those identified here, that are inherently and
unavoidably at risk. Thus, the initial aggregation of the primary
amyloid proteins, such as Ab and a-synuclein, may trigger an
aggregation cascade that disrupts cellular pathways involving
these supersaturated proteins.
In conclusion, we have shown that the presence of a large
number of supersaturated proteins in the human proteome ratio-
nalizes a wide variety of aggregation phenomena associated
with aging and disease. The finding that such proteins are over-
represented in a broad range of biochemical processes linked to
neurodegenerative diseases reveals why such processes are
particularly vulnerable to the appearance of aggregated species
or other factors that compromise proteins homeostasis. We
anticipate that the type of analysis that we have described can
provide a general and widely applicable basis for tracking the
instability of proteomes under specific circumstances. By ex-
ploiting recent advances in techniques for proteomic analysis,
it may soon become possible to use supersaturation measures
to assess quantitatively the vulnerability of the human proteome
to aggregation and the risk of neurodegenerative disease in
individuals over the course of their lives.
EXPERIMENTAL PROCEDURES
The concentration and aggregation propensity of a given protein were com-
bined to produce the supersaturation score s=C+Z, where C is the logarithm
of the concentration derived from the mRNA expression or protein abundance
levels (see Tables S1 and S2), and Z is the Zyggregator score. The s scores
were then recentered such that the median of each database was zero and
used to analyze proteins associated with widespread aggregation (Chapman
et al., 2006; David et al., 2010; Gidalevitz et al., 2006; Koplin et al., 2010; Liao
et al., 2004; Olzscha et al., 2011; Reis-Rodrigues et al., 2012; Wang et al.,
2005; Xia et al., 2008), by comparing them to a control lysate when available,
or to the full proteome database otherwise. Similar procedures were followed
for protein complexes (Licata et al., 2012; Luc and Tempst, 2004). A summary
of data sets used in this study is provided in Tables 1 and S2. DAVID (Gida-
levitz et al., 2006) was used to find KEGG (Kanehisa et al., 2010) pathways
enriched in proteins at or above the 95th percentile of each s score, with
the full database set as background. Error tests were performed by intro-
ducing Gaussian noise into the full su and sf databases in 100 independent
trials or by changing the weighting of aggregation propensity in the uncen-
tered scores, and then recomputing Mann-Whitney U p values and median
fold changes each time.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and three tables and can be found with this article online at
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